Question
Link to data: https://docs.google.com/spreadsheets/d/1mDCGaeQ8Tj_tk_0BdrsWOIb8t7kaHKweo9o9GgUobyo/edit?usp=sharing Please provide excel solution for these: Question 1(a): In each month separately (September, October, and November) and across all 3 months,
Link to data: https://docs.google.com/spreadsheets/d/1mDCGaeQ8Tj_tk_0BdrsWOIb8t7kaHKweo9o9GgUobyo/edit?usp=sharing
Please provide excel solution for these:
Question 1(a): In each month separately (September, October, and November) and across all 3 months, for patients
switched to Med B, what is the average number of weeks the patients were on Med A before being
switched to Med B? (see time on medication definition below)
(b) What is the average total monthly dose per patient per month (in patients that switched) of Medication A before switching to Medication B (use time from question 5)? What is the average total monthly dose per patient per month of Medication B (in patients that switched - assume Med B dose is for 1 month)?
(c) If Medication A cost $1 for 100 units, what is the breakeven price point for Medication B (per unit of B)?
(d) How much does the average total monthly dose per patient (Medication A and B) change for patients switched September vs October vs November?
(e) In patients that were switched to Med B, what percent of the 2nd Med B dose (total dose in month following 1st dose) was the same as the 1st Med B dose? Higher than the 1st dose? Lower than the first dose (but not a zero dose)? No dose at all (a zero dose)? (calculate for patients switched in September only, October only, and Sept and Oct together, assume Med B dose is for 1 month only)
(f) For patients that switch from Med A to Med B (question 4), what's the average LAB B value for these patients when they were on Med A? Med B?
(g)Assume that more of medication A and B is generally associated with higher LAB B values. How does your answer to question 9 and 10 impact the breakeven price point?
Background Notes:
- XYZ client currently uses Medication A in all their patients and is considering a switch to Medication B. A
critical part of the evaluation of Medication B is how much of Medication B would be used in the XYZ client's patients. A trial of Medication B was conducted. The data in the excel file encompasses roughly 130 patients with data at least 2 months before switching medications and up to 3 months on the new medication.
- Patients can be on medication A or medication B or neither medication, but not both medications at the same time
Medication B is given less frequently (~1/month) than Medication A
- The units of Medication A and Medication B are different and are not interchangeable or able to be converted from one to another
- For time on medication, assume the patient is "on" Med A from the first recorded date of Med A administration until the last recorded date of Med A administration
- Assume a week is 7 days and a month is 4.33 weeks
Step by Step Solution
There are 3 Steps involved in it
Step: 1
Get Instant Access to Expert-Tailored Solutions
See step-by-step solutions with expert insights and AI powered tools for academic success
Step: 2
Step: 3
Ace Your Homework with AI
Get the answers you need in no time with our AI-driven, step-by-step assistance
Get Started